Activation of Ras/MAPK and mTOR pathways in hepatocellular carcinoma: Tumor growth inhibition with Ras/mTOR pathway abrogation by a novel combination of Sorafenib and rapamycin — Philippa Newell (2007) | RDL Network
Activation of Ras/MAPK and mTOR pathways in hepatocellular carcinoma: Tumor growth inhibition with Ras/mTOR pathway abrogation by a novel combination of Sorafenib and rapamycin
Journal of the American College of Surgeons 205(3): S93-S94
Pippa Newell, Augusto Villanueva, Judit Peix, Stijn van Laarhoven, Isabel Fiel, Swan N. Thung, Steven Yea, Sasan Roayaie, Myron Schwartz, Scott L. Friedman, Josep M. Llovet
Anja Lachenmayer, Clara Alsinet, Radoslav Savić, Laia Cabellos, S. Toffanin, Yujin Hoshida, A. Villanueva, Beatriz Mínguez, Pippa Newell, Hsin‐Tzu Tsai, Jordi Barretina, S N Thung, Stephen C. Ward, Jordi Bruix, Vincenzo Mazzaferro, M. Schwartz, Scott L. Friedman, Josep M. Llovet
Pippa Newell, Sara Toffanin, Augusto Villanueva, Derek Y. Chiang, Beatriz Mínguez, Laia Cabellos, Radoslav Savić, Yujin Hoshida, Kiat Hon Lim, Pedro Melgar‐Lesmes, Steven Yea, Judit Peix, Kemal Denız, Maria Isabel Fiel, Swan N. Thung, Clara Alsinet, Victoria Tovar, Vincenzo Mazzaferro, Jordi Bruix, Sasan Roayaie, Myron Schwartz, Scott L. Friedman, Josep M. Llovet
Josep M. Llovet, Philippe Merle, Karl Heinz Weiss, Thomas Yau, Paul J. Ross, Vincenzo Mazzaferro, Jean–Frédéric Blanc, Yuk Ting, Chia Jui Yen, Judit Kocsis, Su Pin Choo, Wattana Sukeepaisarnjaroen, René Gérolami, Jean‐François Dufour, Edward Gane, Baek‐Yeol Ryoo, Markus Peck‐Radosavljevic, Thông Dao, Winnie Yeo, Wisut Lamlertthon, Satawat Thongsawat, Michael Teufel, Heiko Krissel,
Discussion(0)
No comments yet. Be the first to comment.